FDA Adverse Event Injury Summary report: N

HAKIM PROGRAMMABLE MICRO VALVE

MDR report key: 6960596 · Received October 18, 2017

Report

Report Number
1226348-2017-10776
Event Type
Injury
Date Received
October 18, 2017
Date of Event
September 28, 2017
Manufacturer
CODMAN & SHURTLEFF, INC. / MEDOS S.A.
Product Code
JXG
PMA / PMN Number
K980778
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). UPON COMPLETION OF THE INVESTIGATION, A FOLLOW UP REPORT WILL BE FILED.

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE WAS RETURNED FOR EVALUATION. THE POSITION OF THE CAM WHEN VALVE WAS RECEIVED WAS 140 MMH2O. THE VALVE WAS VISUALLY INSPECTED; NO ISSUES WERE OBSERVED. THE VALVE WAS TESTED FOR PROGRAMMING AND FAILED; THE CAM MECHANISM DID NOT MOVE DURING THE PROGRAMMING PROCESS. THE VALVE WAS FLUSHED, NO OCCLUSION WAS NOTED. A LEAK TEST WAS PERFORMED AND PASSED. A REFLUX WAS PERFORMED AND PASSED. THE VALVE WAS DISMANTLED AND WAS EXAMINED UNDER MICROSCOPE AT APPROPRIATE MAGNIFICATION: BIOLOGICAL DEBRIS WAS FOUND ON THE SPRING, ON THE SPRING PILLAR, THE CAM MECHANISM, AND ON THE BASE PLATE. THE MAGNETS WERE CONTROLLED AND PASSED TESTING. REVIEW OF THE HISTORY DEVICE RECORDS CONFIRMED THE VALVE PRODUCT CODE 82-3112, WITH LOT CVGBGC CONFORMED TO SPECIFICATIONS WHEN RELEASED TO STOCK. THE ROOT CAUSE OF THE PROGRAMMING PROBLEM WAS DUE TO THE BIOLOGICAL DEBRIS FOUND THE VALVE ROTOR AND STATOR. TRENDS WILL BE MONITORED FOR THIS OR SIMILAR COMPLAINTS. AT PRESENT, WE CONSIDER THIS COMPLAINT TO BE CLOSED.

Description of Event or Problem · 1

(B)(4). THE VALVE STOPPED TO WORK PROBABLY DUE TO A BLOCK OF THE KNOB. IT WAS REPLACED. REVISION SURGERY WAS NECESSARY+ ANTIBIOTIC THERAPY. PATIENT GENDER: M. THERE WAS NO REPORT OF INFECTION TO CAUSE THE USE OF ANTIBIOTIC.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
739091 HAKIM PROGRAMMABLE MICRO VALVE SHUNT, CENTRAL NERVOUS SYSTEM & COMPS JXG CODMAN & SHURTLEFF, INC. / MEDOS S.A. CVGBGC

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention